M. Umar
Holy Family Hospital
1 Papers
M. Umar is an academic researcher from Holy Family Hospital. The author has contributed to research in topics: Hepatitis C & Viral hepatitis. The author has an hindex of 1, co-authored 1 publications. Previous affiliations of M. Umar include University of Indonesia & Rawalpindi Medical College.
Chat about Author
Papers
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
A. Sibley,Kwang Hyub Han,A. Abourached,Laurentius A. Lesmana,Mihály Makara,Wasim Jafri,Riina Salupere,Abdullah M. Assiri,Adrian Goldis,Faisal Abaalkhail,Zaigham Abbas,A. Abdou,F. Al Braiki,F. Al Hosani,K. Al Jaberi,M. Al Khatry,M. A. Al Mulla,H. Al Quraishi,A. Al Rifai,Y. Al Serkal,Altaf Alam,Seyed Moayed Alavian,Hamad I. Al-Ashgar,S. Alawadhi,L. Al-Dabal,P. Aldins,Faleh Z. Al-Faleh,Abdullah S. Alghamdi,R. Al-Hakeem,Abdulrahman Aljumah,A. Almessabi,Adel Alqutub,Khalid Alswat,Ibrahim Altraif,M. Alzaabi,N. Andrea,Mohamed A. Babatin,A. Baqir,M. T. Barakat,Ottar M. Bergmann,Abdul Rahman Bizri,Sarah Blach,Asad Chaudhry,M. S. Choi,T. Diab,Samsuridjal Djauzi,E. S. El Hassan,S. El Khoury,Chris Estes,S. Fakhry,J. I. Farooqi,J. I. Farooqi,H. Fridjonsdottir,Rino Alvani Gani,A. Ghafoor Khan,Liana Gheorghe,Magnus Gottfredsson,S. Gregorcic,Jessie Gunter,Behzad Hajarizadeh,Behzad Hajarizadeh,Saeed Hamid,Irsan Hasan,Almoutaz Hashim,Gabor Horvath,Béla Hunyady,R. Husni,Agita Jeruma,Jon G. Jonasson,Jon G. Jonasson,B. Karlsdottir,Do Young Kim,Young Seok Kim,Z. Koutoubi,Valentina Liakina,Valentina Liakina,Young-Suk Lim,A. Löve,A. Löve,Matti Maimets,Reza Malekzadeh,Mojca Maticic,Muhammad S. Memon,Shahin Merat,Jacques E Mokhbat,Fadi H. Mourad,David H. Muljono,David H. Muljono,Arif Nawaz,N. Nugrahini,S. Olafsson,S. Priohutomo,H. Qureshi,P. Rassam,Homie Razavi,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Baiba Rozentale,M. Sadik,K. Saeed,A. Salamat,Faisal M. Sanai,A. Sanityoso Sulaiman,R. A. Sayegh,Ala I. Sharara,M. Siddiq,A. M. Siddiqui,G. Sigmundsdottir,B. Sigurdardottir,Danute Speiciene,Andri Sanityoso Sulaiman,Marwa Sultan,M. Taha,Junko Tanaka,H. Tarifi,G. Tayyab,Ieva Tolmane,M. Ud Din,M. Umar,M. Umar,M. Umar,Jonas Valantinas,J. Videčnik-Zorman,Cesar Yaghi,Evy Yunihastuti,M. A. Yusuf,Bader Faiyaz Zuberi,Jonathan Schmelzer +127 more
TL;DR: The current treatment rate and efficacy are not sufficient to manage the disease burden of hepatitis C virus and alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver‐related deaths from increasing.